Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
---|
10/12/2000 | CA2366944A1 Pyrrolidine modulators of chemokine receptor activity |
10/12/2000 | CA2365834A1 Herbal compositions and uses for the treatment of allergic reactions |
10/12/2000 | CA2365421A1 Vesicle associated proteins |
10/11/2000 | EP1043329A1 Crystal of diuridine tetraphosphate or salt thereof and method for preparing the same, and method for producing said compound |
10/11/2000 | EP1042674A1 148 human secreted proteins |
10/11/2000 | EP1042468A2 Low-voltage activated calcium channel compositions and methods |
10/11/2000 | EP1042329A1 Novel farnesyl transferase inhibitors, preparation, pharmaceutical, compositions containing them and use for preparing medicines |
10/11/2000 | EP1042319A1 Dihydrobenzofurans |
10/11/2000 | EP1042300A1 Phthalazine derivatives phosphodiesterase 4 inhibitors |
10/11/2000 | EP1042297A1 Carboxyl acid substituted heterocycles as metalloproteinase inhibitors |
10/11/2000 | EP1042279A1 Substituted beta-alanines |
10/11/2000 | EP1041990A1 Composition for treating respiratory and skin diseases, comprising at least one leukotriene antagonist and at least one antihistamine |
10/11/2000 | EP1041989A1 Novel cycloalkenyl substituted compounds |
10/11/2000 | EP1041982A1 INHIBITION OF p38 KINASE ACTIVITY USING SUBSTITUTED HETEROCYCLIC UREAS |
10/11/2000 | EP1041966A2 Pharmaceutical compositions |
10/11/2000 | CN1269722A Method and composition for modulating responsiveness to corticosteroids |
10/11/2000 | CN1269715A Method and composition for treating late allergic reactions and inflammation diseases |
10/11/2000 | CN1057296C Morpholine and thiomorpholine tachykinin receptor antagonists and use |
10/11/2000 | CN1057225C Process for preparing charantin |
10/11/2000 | CN1057214C Cooling throat oral liquor and preparation technology |
10/11/2000 | CN1057212C Oral liquor for body-building |
10/10/2000 | US6130233 Methods and compositions for treating allergic disorders and other disorders using metabolic derivatives of astemizole |
10/10/2000 | US6130226 Immunotherapeutic agents |
10/10/2000 | US6129913 Recombinant IL-5 antagonists useful in treatment of IL-5 mediated disorders |
10/10/2000 | CA2147606C Stable extended release oral dosage composition |
10/05/2000 | WO2000058512A1 Antisense modulation of interleukin-5 signal transduction |
10/05/2000 | WO2000058495A1 45 human secreted proteins |
10/05/2000 | WO2000058494A1 50 human secreted proteins |
10/05/2000 | WO2000058475A2 Streptococcus pneumoniae antigens |
10/05/2000 | WO2000058473A2 Nucleic acids including open reading frames encoding polypeptides; 'orfx' |
10/05/2000 | WO2000058468A2 47 human secreted proteins |
10/05/2000 | WO2000058467A1 50 human secreted proteins |
10/05/2000 | WO2000058466A2 Protease resistant flint analogs |
10/05/2000 | WO2000058465A2 Flint polypeptide analogs |
10/05/2000 | WO2000058355A1 50 human secreted proteins |
10/05/2000 | WO2000058348A1 Treatment of bone disorders with adrenomedullin or adrenomedullin agonists |
10/05/2000 | WO2000058339A2 50 human secreted proteins |
10/05/2000 | WO2000058334A1 50 human secreted proteins |
10/05/2000 | WO2000058309A1 Derivatives of pyrimido[6,1-a]isoquinolin-4-one |
10/05/2000 | WO2000058308A1 DERIVATIVES OF PYRIMIDO[6,1-a]ISOQUINOLIN-4-ONE |
10/05/2000 | WO2000058307A2 Aryl fused 2,4-disubstituted pyridines: nk3 receptor ligands |
10/05/2000 | WO2000058305A1 Novel compounds |
10/05/2000 | WO2000058295A2 Compounds and methods for treatment of asthma, allergy and inflammatory disorders |
10/05/2000 | WO2000058292A1 Novel morpholine derivatives, method for the production thereof and pharmaceutical preparations containing said derivatives |
10/05/2000 | WO2000057920A2 Method for expressing proteins |
10/05/2000 | WO2000057913A1 Preventives/remedies for interstitial pneumonia and pulmonary fibrosis |
10/05/2000 | WO2000057903A2 48 human secreted proteins |
10/05/2000 | WO2000057901A1 Modulation of vascular permeability by means of tie2 receptor activators |
10/05/2000 | WO2000057897A1 Use of a lectin or conjugates for modulation of c-fibre activity |
10/05/2000 | WO2000057890A1 Pulmonary delivery of protonated/acidified nucleic acids |
10/05/2000 | WO2000057880A1 Methods and compositions for treating allergic and related disorders using fluorinated descarboethoxyloratadine |
10/05/2000 | WO2000057701A1 Prostaglandin compounds, compositions and methods of treating peripheral vascular disease and pulmonary hypertension |
10/05/2000 | WO2000031280A3 Use of plus-strand synthesis elements in retroviral vectors |
10/05/2000 | WO2000029574A3 Inflammation-associated genes |
10/05/2000 | WO2000026243A3 Transmembrane 4 proteins |
10/05/2000 | WO1998041232A3 Compositions for modulating responsiveness to corticosteroids |
10/05/2000 | DE10004860A1 Pressurized air inhaler for administering drug-containing liposomal powder aerosol for treatment of respiratory disease, has nebulization chamber for drying aqueous liposome suspension |
10/05/2000 | CA2383592A1 2384891 acids including open reading frames encoding polypeptides; orfx |
10/05/2000 | CA2369458A1 47 human secreted proteins |
10/05/2000 | CA2368951A1 50 human secreted proteins |
10/05/2000 | CA2368927A1 45 human secreted proteins |
10/05/2000 | CA2368881A1 50 human secreted proteins |
10/05/2000 | CA2368760A1 Flint polypeptide analogs |
10/05/2000 | CA2368719A1 50 human secreted proteins |
10/05/2000 | CA2368641A1 Use of a lectin or conjugates for modulation of c-fibre activity |
10/05/2000 | CA2368467A1 50 human secreted proteins |
10/05/2000 | CA2368460A1 Derivatives of pyrimido¬6,1-a|isoquinolin-4-one |
10/05/2000 | CA2368442A1 48 human secreted proteins |
10/05/2000 | CA2368281A1 50 human secreted proteins |
10/05/2000 | CA2368090A1 Compounds and methods for treatment of asthma, allergy and inflammatory disorders |
10/05/2000 | CA2367882A1 Treatment of bone disorders with adrenomedullin or adrenomedullin agonists |
10/05/2000 | CA2366305A1 Method for expressing proteins |
10/05/2000 | CA2365401A1 Aryl fused 2,4-disubstituted pyridines: nk3 receptor ligands |
10/05/2000 | CA2361366A1 Novel compounds |
10/05/2000 | CA2359652A1 Novel prostaglandin compounds and derivatives thereof, compositions containing the same and method of using the same for the treatment of peripheral vascular disease and pulmonaryhypertension |
10/04/2000 | EP1041072A1 Dioxocyclopentyl hydroxamic acids |
10/04/2000 | EP1040838A1 Stable aqueous EM 12 solution |
10/04/2000 | EP1040191A2 Rantes mutants and therapeutic applications thereof |
10/04/2000 | EP1040190A1 Serine proteinase inhibitors |
10/04/2000 | EP1040101A1 Substituted 2-aryl-4-amino-chinazolines, method for the production and use thereof as medicaments |
10/04/2000 | EP1040100A1 Therapeutically active compounds based on indazole bioisostere replacement of catechol in pde4 inhibitors |
10/04/2000 | EP1040099A1 Azepine or larger medium ring derivatives and their use as pharmaceuticals |
10/04/2000 | EP1040097A1 Potassium channel openers |
10/04/2000 | EP1039935A1 USE OF NUCLEIC ACIDS CONTAINING UNMETHYLATED CpG DINUCLEOTIDE IN THE TREATMENT OF LPS-ASSOCIATED DISORDERS |
10/04/2000 | EP1039911A1 MORPHOLINO-N-ETHYL ESTER PRODRUGS OF INDOLE sPLA 2 INHIBITORS |
10/04/2000 | EP1039904A1 Synergistic antimicrobial compositions |
10/04/2000 | EP1039903A1 Il-8 receptor antagonists |
10/04/2000 | EP1039804A1 Method for treating fibroproliferative disorders by inhibitors of protein hydroxylation |
10/04/2000 | EP1023279A4 Compounds and method for preparing substituted 4-phenyl-4-cyanocyclohexanoic acids |
10/04/2000 | EP1019040A4 INHIBITION OF p38 KINASE ACTIVITY BY ARYL UREAS |
10/04/2000 | EP0772610B1 Dihydrobenzofuranes |
10/04/2000 | EP0699236B1 Purified mammalian flt3 ligands and agonists and antagonists thereof |
10/04/2000 | CN1268938A Aminocycloalkane compounds |
10/04/2000 | CN1057007C Application of theaflavine for preparing medicine for treating pulmonitis |
10/04/2000 | CN1056974C Method for preparing drug material suitable for micronisation |
10/03/2000 | US6127554 2,4-bis[(4-amidino)phenyl]furans as anti-Pneumocystis carinii agents |
10/03/2000 | US6127542 Chemical intermediates to specified pyrazino(2',1':6,1)pyrido(3,4b)indole-1,4-diones which are selective inhibitors of cyclic guanosine 3',5'-monophosphate specific phosphodiesterase; to treat cardiovascular disorders |
10/03/2000 | US6127423 Phenylamidine derivatives, a process for preparing the same and their use as medicaments |
10/03/2000 | US6127408 Thioether furan nitrone compounds; nervous system degenerative disorders, e.g. alzheimer's disease; analysis of free radicals by forming adducts; inhibit the forming of a beta(1-42) beta-pleated sheets and/or suppressing cytokines |
10/03/2000 | US6127401 Treatment of prostate disorders, angiogenic disorders, neoplasia, rheumatoid arthritis, pulmonary fibrosis, myelofibrosis, abnormal wound healing, atherosclerosis, or restenosis, alzheimer's disease |